Back to top

Analyst Blog

Symmetry Surgical, a subsidiary of orthopedic implants and instruments maker Symmetry Medical, Inc. (SMA - Analyst Report), launched its Bookwalter Self-Retaining Rotilt Ratchet at the 60th Congress of the Association of periOperative Registered Nurses (AORN) in San Diego. The advanced device is the latest component of the leading Bookwalter Retractor System, which incorporates the best features of the past generation into a single light-weight ratchet with a low-profile design.

The Bookwalter portfolio was developed by Codman & Shurtleff, Inc. (Codman), a Johnson & Johnson (JNJ - Analyst Report) enterprise, acquired by Symmetry in Dec 2011. Symmetry absorbed Codman’s surgical instrument product line into its hospital direct setup, Specialty Surgical Instrumentation ("SSi"). The integrated direct general surgical instruments operation has been named as Symmetry Surgical.

Since Symmetry Medical’s core Original Equipment Manufacturer (“OEM”) Solutions business is facing declining capital spending, as well as procedural and pricing pressure from the weak global orthopedic market, the company is focused on expanding its smaller Symmetry Surgical business.

In the fourth quarter of 2012, revenues from the smaller Symmetry Surgical unit jumped 154% to $28.5 million, buoyed by the acquisition of Codman & Shurtleff, Inc., which contributed roughly $13.1 million to the division’s sales. Revenues also include a one-time purchase of an OEM Solutions client worth $2.9 million. Excluding the acquisition and the one-time purchase, sales increased 10.4% year over year in the quarter.

However, the company currently has a Zacks Rank #4 (Sell), as both revenues and earnings missed the Zacks Consensus Estimates in the fourth quarter of 2012. While we remain pessimistic regarding Symmetry, companies such as Nuvasive Inc. (NUVA - Snapshot Report) and Cyberonics Inc. (CYBX - Analyst Report) , each carrying a Zacks Rank #1 (Strong Buy), warrant a look.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UTD THERAPE… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%